MedTrace Logo

Microbiome, Antibiotics, and Growth Infant Cohort

NCT03001167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 509

Last updated 2024-01-12

No results posted yet for this study

Summary

This cross-disciplinary study will assemble and longitudinally follow a large, diverse birth cohort to determine the relationships between early life antibiotic exposure, microbiome development, growth, antibodies, and immunostimulation.

Conditions

  • Obesity, Childhood
  • Antibiotic Side Effect

Sponsors & Collaborators

Principal Investigators

  • Jeffrey S Gerber, MD, PhD · Children's Hospital of Philadelphia

  • Dan Knights, PhD · University of Minnesota

Eligibility

Max Age
96 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-09
Primary Completion
2021-10-22
Completion
2023-06-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03001167 on ClinicalTrials.gov